Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-01-04 @ 4:41 PM
Study NCT ID:
NCT02862132
Status:
COMPLETED
Last Update Posted:
2022-10-25
First Post:
2016-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
Sponsor:
Shaare Zedek Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-31
First Submit QC Date:
None
Study First Post Date:
2016-08-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-24
Last Update Post Date:
2022-10-25
Last Update Post Date Type:
ACTUAL